probucol has been researched along with Prostatic Hyperplasia in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seventy patients were administered either Probucol, an anti-cholesterol agent or a placebo in a double blind manner for a period of 1 year in an effort to assess the effectiveness of this agent in treating benign prostatic hyperplasia." | 7.66 | Assessment of the antihypercholesterolemic drug, Probucol, in benign prostatic hyperplasia. ( Boyce, WH; Jackson, JE; Resnick, MI; Watts, LE, 1983) |
| "Seventy patients were administered either Probucol, an anti-cholesterol agent or a placebo in a double blind manner for a period of 1 year in an effort to assess the effectiveness of this agent in treating benign prostatic hyperplasia." | 3.66 | Assessment of the antihypercholesterolemic drug, Probucol, in benign prostatic hyperplasia. ( Boyce, WH; Jackson, JE; Resnick, MI; Watts, LE, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Resnick, MI | 1 |
| Jackson, JE | 1 |
| Watts, LE | 1 |
| Boyce, WH | 1 |
1 other study available for probucol and Prostatic Hyperplasia
| Article | Year |
|---|---|
Assessment of the antihypercholesterolemic drug, Probucol, in benign prostatic hyperplasia.
Topics: Cholesterol; Double-Blind Method; Drug Evaluation; Humans; Male; Phenols; Probucol; Prostatic Hyperp | 1983 |